ReviewMedicine international
Neurochagas: Experimental and human literature of an uncommon entity (Review).
Review in Medicine international. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Highlights in Cysteine Protease Inhibitors as Antiparasitic Agents Against Trypanosomatids.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurochagas, the neurological manifestation of Chagas disease, presents a challenge to global health, affecting millions of individuals worldwide. Despite significant progress being made in the understanding of the pathogenesis and clinical presentation of neurochagas, numerous gaps persist in the literature, hindering effective diagnosis and management. The present review discusses the relevant experimental and human literature regarding neurochagas and its epidemiology, pathophysiology, clinical manifestations, diagnostic approaches, treatment strategies and future directions for research. Neurochagas includes a broad spectrum of neurological manifestations, including meningoencephalitis, stroke-like syndromes, cognitive impairment, movement disorders, peripheral neuropathy and autonomic dysfunction, resulting from
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.